Analgesic Activity of Hexaazaisowurtzitane Derivatives
- Authors: Krylova S.G.1, Povet’eva T.N.1, Zueva E.P.1, Suslov N.I.1, Amosova E.N.1, Razina T.G.1, Lopatina K.A.1, Rybalkina O.Y.1, Nesterova Y.V.1, Afanas’eva O.G.1, Kiseleva E.A.1, Sysolyatin S.V.2, Kulagina D.A.2, Zhdanov V.V.1
- 
							Affiliations: 
							- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
- Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences
 
- Issue: Vol 166, No 4 (2019)
- Pages: 461-465
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/241104
- DOI: https://doi.org/10.1007/s10517-019-04372-9
- ID: 241104
Cite item
Abstract
Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.
About the authors
S. G. Krylova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
							Author for correspondence.
							Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
T. N. Povet’eva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
E. P. Zueva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
N. I. Suslov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
E. N. Amosova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
T. G. Razina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
K. A. Lopatina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
O. Yu. Rybalkina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
Yu. V. Nesterova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
O. G. Afanas’eva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
E. A. Kiseleva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
S. V. Sysolyatin
Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Biysk						
D. A. Kulagina
Institute of Problems of Chemical and Energetic Technologies, Siberian Division of the Russian Academy of Sciences
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Biysk						
V. V. Zhdanov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center
														Email: krylova5935@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					